Latest Biotechnology, Pharmaceutical and Healthcare News from Novartis

00:23 EDT 21st October 2018 | BioPortfolio

Here are the most relevant search results for "Novartis" found in our extensive news archives from over 250 global news sources.

More Information about Novartis on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Novartis for you to read. Along with our medical data and news we also list Novartis Clinical Trials, which are updated daily. BioPortfolio also has a large database of Novartis Companies for you to search.

Showing News Articles 1–25 of 84 from Novartis

Thursday 4th October 2018

Women in Science: Marjorie Eiref

Many people who work in the healthcare industry do so because they want to help people. For Marjorie Eiref, family also plays a ...

Wednesday 29th August 2018

The ABCDEs of melanoma prevention and detection

It is ...

Tuesday 21st August 2018

Teaming up with academia to discover medicines

Humans carrying a certain rare combination of two genetic mutations experience something unexpected. One mutation causes sickle cell disease, a lifelong and debilitating form of anemia that affects millions worldwide. The other appears to cancel out the first. Individuals with both mutations show no symptoms of disease.Hematologist Stuart Orkin and other experts in the field think that the second ...

Researchers boost understanding of T-cell therapy in blood cancer

Most children and young adults with acute lymphoblastic leukemia (ALL) who received a Novartis T-cell immunotherapy in two clinical trials responded to the treatment1. Scientists typically didn’t find any molecular traces of the aggressive blood cancer after the treatment, tisagenlecleucel, a form of chimeric antigen receptor T-cell (CAR-T) therapy in which the patient’s own T-cells are geneti...

Neuroscientists target Alzheimer’s “silent stage”

The latest research into what is known as the “silent stage” of Alzheimer’s disease has prompted many experts to believe that early intervention may offer the best chance of therapeutic success.The “silent stage” of Alzheimer’s concerns what goes on inside the brain before symptoms appear and is today a major focus of current research. Neuroscientists are particularly interested in the...

Thursday 2nd August 2018

New drug manufacturing tools change pharma chemistry

Most medicines are made the old-fashioned way. In fact, the process hasn’t changed much for over a hundred years. Engineers mix large amounts of chemical materials together in industrial-sized vats, the way a baker might make a very large batch of cookies.It’s a reliable system, but not very flexible.Recent advances in chemical engineering and automation, however, have ushered in a new era for...

Wednesday 1st August 2018

Embracing big data to understand complex diseases

In 1967, in response to a life-shortening heart disease epidemic in the Western world, the Icelandic Heart Association (IHA) launched the Reykjavik Study, a research program intended to get at the roots of heart disease and find ways to stop it. Researchers recruited 30 000 Icelanders to join the study, which morphed into another study that still runs to this day.Researchers from Novartis and IHA ...

Monday 23rd July 2018

Discovery gives cystic fibrosis researchers new direction

When scientists discovered the gene that causes cystic fibrosis in 1989, they were optimistic that a cure was on the horizon. As the years passed by, hundreds of mutations were identified in the gene, but new treatments were slow to emerge and a cure has yet to materialize. One major reason for the delay is that scientists have had trouble figuring out precisely where the gene is active. Now they ...

Friday 29th June 2018

Drug development gets big data analytics boost

Today, the power of data analytics is informing strategies and business practices across industries. Football clubs are chasing players with specific skills to strengthen a side’s qualities, and Formula 1 teams are analyzing every turn of the wheel to squeeze out milliseconds to win races. The promise of big data and advanced analytics, which has been fueled by a quantum leap in computing over t...

Friday 1st June 2018

Open resources at Novartis help drive innovation

“Back in Argentina, you never think of going for a real drug, but coming to Novartis completely changed what I thought was possible,” says Bernardo Bazet Lyonnet, a postdoctoral researcher who first came to Novartis in 2016 as a Next Generation Scientist (NGS). This program invites talented scientists from around the world for a bi-directional learning exchange at the Novartis campus in Basel,...

Thursday 17th May 2018

Immuno-oncology researchers seek to build smart drug combos

Immunotherapies for cancer have been life-changing for patients who respond to them. Yet, overall, only about 20% of patients respond to these drugs. To expand the reach of these medicines, approximately 1 100 clinical trials have been launched by companies and research institutions over the past few years to test them in a range of combinations. This is a huge number of clinical trials – each ...

Monday 14th May 2018

Quest for a new measure of mental health

There’s no blood or spinal fluid test for depression, schizophrenia or bipolar disorder. Rather, these disorders are evaluated the old-fashioned way: using pencil and paper.For over half a century, questionnaires have been used to assess the mental state of patients. But it isn’t just the diagnostic tools that have stagnated. Medicines for neuropsychiatric disorders haven’t changed much eith...

Women in Science: Mimi Huizinga

As part of our “Novartis Presents: Women in Science” series, we ...

Monday 30th April 2018

Machine learning poised to accelerate drug discovery

A technology called machine learning is behind that seemingly magical ability of social networking websites to identify people in posted photos. By analyzing subtle patterns in facial features, machine learning algorithms can recognize people you’ve never tagged and might not even know.Machine learning is also transforming how scientists at Novartis discover and develop new drugs. Similar to how...

T.J. Sharpe on why clinical trials matter

For this installment of my blog ...

Tuesday 10th April 2018

African experts call for renewed global drive to beat malaria

African health experts warn that major advances in tackling malaria have led to widespread complacency and they are calling for a renewed effort to combat the disease.Although global malaria deaths fell more than 60% between 2000 and 2015, experts participating in a recent survey said they fear progress could stall unless national governments provide more funding, and international organizations t...

Thursday 5th April 2018

Meet Martin Grobusch, malaria fighter

Over the last 15 years, huge progress has been made in the fight against malaria, with the number of people dying from the disease dropping by almost two-thirds.1 Yet signs of resistance to existing antimalarial drugs are a rising concern, and the search is on for a replacement. Martin Grobusch is one of the researchers helping to test an experimental new Novartis antimalarial called KAF156. Since...

Monday 2nd April 2018

Counting on combos for complex liver diseases

The liver disease called NASH (non-alcoholic steatohepatitis) is stealthy. Patients don’t have symptoms until the latest stages of the disease, when it almost immediately becomes life threatening. It sneaks by doctors, too, since the disease can only be confirmed with a liver biopsy, an invasive procedure reserved for the seriously ill.NASH is also hard to treat. It’s a bit like four diseases ...

Thursday 22nd March 2018

DNA-encoded molecules provide a new edge in cancer drug hunts

Frederic Berst guides a team that builds libraries. Not the kind that hold books, but the kind that contain millions of chemicals that could someday become drugs. His team’s work, performed at the chemistry bench, is making it possible for drug hunters at Novartis to reimagine the way they search for new medicines for cancer and other diseases.There’s a strong need for new ways to find cancer ...

Tuesday 20th March 2018

Malaria is still disrupting lives, despite progress

Sitting in the small courtyard of his mud house, Adama Kone, the village chief in Bougoula in southeastern Mali, and his council of elders are talking about the importance of the malaria research being done there. Asked if they’ve ever had malaria, Kone and his advisors break into uproarious laughter. They explain they get it every year, and then mime vomiting and having diarrhea. ...

Wednesday 14th March 2018

Building “boot camps” for immune cells near tumors

A new wave of therapies is unleashing the body’s immune system on cancer, significantly extending lives. These agents, however, don’t work for everyone, so scientists are exploring new approaches that might enable immunotherapies to more effectively combat tumors.One idea, born of a team of bioengineers, involves loading baby-aspirin-sized scaffolds with immunotherapy agents and inserting them...

Friday 2nd March 2018

Positive gains are needed to accelerate change for women with lung disease

Last year, a report by the World Economic Forum1 predicted that gender parity is still over 200 years away. More recently, the #MeToo movement has brought sexual harassment in the workplace to the top of the news agenda, and rightly so. No one expects true gender equality to happen overnight, but it’s critical that continued positive progress is made in all areas of society and culture – inclu...

Friday 16th February 2018

Taking on obesity

As a cardiologist at the Veterans Affairs (VA) Medical Center in Boston, Will Chutkow treats patients who have served in the US military. Because these patients are predominantly male, drink and smoke at an above-average rate, and have had stressful jobs, they are in the high-risk group for heart disease. Many are also among the 38% of US adults who suffer from obesity – a major risk factor for ...

Tuesday 13th February 2018

Women in Science: Fionnuala Doyle

In this installment of “ ...

Monday 5th February 2018

Potential weight loss treatment takes shape with help from patients

James Zervios grew up in a time when schoolyard bullying was met with a shrug. Teased for his weight and picked last for sports teams, Zervios sought solace at the end of the day in the comforts of home. In his Italian and Greek household, comfort was often in the form of food. His family celebrated every life event with an Italian feast and gathered each Sunday for a four-course family dinner, so...

Quick Search


News Quicklinks